Evidence map›Paper›PMID 41143000›Full record

ArticleiScience2025

Analysis of neuronal activity impairment in iPSC-derived neurons from idiopathic autism patients.

Andras Kern, Viktor Román, Tamás I Orbán, Ildikó Pál, József Nagy, György Lévay, Balázs Lendvai, Zsolt Némethy

Abstract read
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Andras KernPharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Viktor RománPharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Tamás I OrbánInstitute of Molecular Life Sciences, Research Centre for Natural Sciences, HUN-REN, Budapest, Hungary.
Ildikó PálPharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
József NagyPharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
György LévayDepartment of Morphology and Physiology, Faculty of Health Sciences, Semmelweis University, Budapest, Hungary.
Balázs LendvaiPharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.
Zsolt NémethyPharmacological and Drug Safety Research, Gedeon Richter Plc., Budapest, Hungary.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding the molecular mechanisms underlying autism spectrum disorder (ASD) is crucial to develop effective interventions. Here, we utilized induced pluripotent stem cells differentiated into neurons (iPSC-Ns) from idiopathic ASD and control individuals (CTRL) to investigate the molecular basis of ASD. ASD-iPSC-Ns exhibited functional alterations displaying less calcium transients compared to CTRL. Different expression levels of microRNAs involved in neurogenesis and neuronal functioning might underlie these differences. ASD-iPSC-N neuronal networks showed impaired synaptic neurotransmission and connectivity (decreased [Ca

Indexed as

cell biologymolecular biologyneuroscience

Identifiers

PMID41143000
PMCPMC12546973

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.